Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.32 |
| ▸ | TET3 | O43151 | 1/20 | 0.32 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12767798 | 1.00 | OR51E2 (0.43) | OR51E2LMNAALDH1A1SLC22A6THRB | |
| SCHEMBL15819973 | 1.00 | OR51E2 (0.43) | OR51E2LMNAALDH1A1SLC22A6THRB | |
| Pyruvate SCHEMBL27211554 | 0.82 | OR51E2 (0.30) | OR51E2 | |
| SCHEMBL29864833 | 0.79 | LMNA (0.38) | OR51E2LMNAALDH1A1SLC22A6THRB | |
| SCHEMBL28207126 | 0.79 | LMNA (0.38) | OR51E2LMNAALDH1A1SLC22A6THRB | |
| SCHEMBL16585311 | 0.79 | THRB (0.43) | OR51E2LMNASLC22A6THRBGABRR1 | |
| SCHEMBL28163079 | 0.79 | LMNA (0.38) | OR51E2LMNAALDH1A1SLC22A6THRB | |
| SCHEMBL1224789 | 0.78 | SLC22A6 (0.72) | OR51E2LMNASLC22A6GABRR1MAPK1 | |
| SCHEMBL9067380 | 0.78 | LMNA (0.42) | OR51E2LMNAALDH1A1SLC22A6THRB | |
| SCHEMBL9067155 | 0.78 | LMNA (0.42) | OR51E2LMNAALDH1A1SLC22A6THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739784-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2026-05-13 | — | — | EP | claimed |
| WO-2025012222-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | ANNIKKI GMBH (AT) | 2025-01-16 | — | — | WO | claimed |
| EP-4488374-A1 | PROCESS FOR PREPARING AN AQUEOUS SOLUTION COMPRISING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2025-01-08 | — | — | EP | claimed |
| CN-115754053-A | Effective diagnostic marker for resisting papillary thyroid carcinoma through radioactive iodine treatment and screening method and application thereof | 浙江省肿瘤医院 | 2023-03-07 | — | — | CN | claimed |
| EP-3280794-B1 | A MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBURYRATE WITH ENHANCED 2,4-DIHYDROXYBUTYRATE EFFLUX | METABOLIC EXPLORER SA (FR) | 2020-05-27 | — | — | EP | claimed |
| EP-4739784-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739784-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025012222-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | ANNIKKI GMBH (AT) | 2025-01-16 | — | — | WO | disclosed |
| WO-2025012222-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | ANNIKKI GMBH (AT) | 2025-01-16 | — | — | WO | disclosed |
| EP-4488374-A1 | PROCESS FOR PREPARING AN AQUEOUS SOLUTION COMPRISING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2025-01-08 | — | — | EP | disclosed |
| EP-4488374-A1 | PROCESS FOR PREPARING AN AQUEOUS SOLUTION COMPRISING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2025-01-08 | — | — | EP | disclosed |
| WO-2024084032-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ALKALINE SALT OF GLYCOLIC ACID AND LACTIC ACID | ANNIKKI GMBH (AT) | 2024-04-25 | — | — | WO | disclosed |
| US-7923226-B2 | Synthesis of 1,2,4-butanetriol enantiomers from carbohydrates | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2011-04-12 | — | — | US | disclosed |
| US-7923226-B2 | Synthesis of 1,2,4-butanetriol enantiomers from carbohydrates | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2011-04-12 | — | — | US | disclosed |
| US-7858775-B2 | Production of 2′-deoxynucleosides and 2′-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate | RHODIA CHIMIE (FR) | 2010-12-28 | — | — | US | disclosed |
| US-20090239249-A1 | NOVEL THERMOSTABLE GLUCONATE DEHYDRATASE AND USE THEREOF | POSCO (KR) | 2009-09-24 | — | — | US | disclosed |
| US-20070212759-A1 | Production Of 2'-Deoxynucleosides And 2'-Deoxynucleoside Precursors From 2-Dehydro-3-Deoxy-D-Gluconate | SCIENTIST OF FORTUNE SA (LU) | 2007-09-13 | — | — | US | disclosed |
| EP-1636246-A1 | PRODUCTION OF 2 -DEOXYNUCLEOSIDES AND 2 -DEOXYNUCLEOSIDE PRECURSORS FROM 2-DEHYDRO-3-DEOXY-D-GLUCONATE | Evologic S.A. (FR) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004113358-A1 | PRODUCTION OF 2'-DEOXYNUCLEOSIDES AND 2'-DEOXYNUCLEOSIDE PRECURSORS FROM 2-DEHYDRO-3-DEOXY-D-GLUCONATE | EVOLOGIC S.A. (FR) | 2004-12-29 | — | — | WO | disclosed |
| CN-1367841-A | Methods and materials for synthesis of organic products | CARGILLDOU CO LTD (US) | 2002-09-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070212759-A1 | Production Of 2'-Deoxynucleosides And 2'-Deoxynucleoside Precursors From 2-Dehydro-3-Deoxy-D-Gluconate | DERA, DUT, SAMHD1 | OR51E2 4406/4885LMNA 2380/4885ALDH1A1 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.